Skip Navigation

Cardiovascular Research 1995 30(5):725-730; doi:10.1016/S0008-6363(95)00099-2
© 1995 by European Society of Cardiology
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bozzo, J.
Right arrow Articles by Ordinas, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bozzo, J.
Right arrow Articles by Ordinas, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1995, European Society of Cardiology

Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin

Jordi Bozzo*, María Rosa Hernández and Antonio Ordinas

Servei d'Hemoteràpia i Hemostàsia, Hospital Clínic i Provincial, Villarroel, 170, 08036 Barcelona, Spain

Objectives: To explore the role of blood flow in red blood cell deformability and determine whether it is associated with the release of ATP by red cells. Methods: A perfusion system was employed to mimic the blood flow conditions. Red cell treatment in vitro with dipyridamole or aspirin, either alone or combined, was performed either on red cells alone prior to blood reconstitution or on already reconstituted blood. Blood viscosity at shear rates of 90 and 450 s–1 was measured, before and after perfusion, by means of a cone/plate viscometer. Red cell deformability was estimated as the magnitude of the slope between these two values of viscosity. ATP level in platelet-free plasma was measured by the firefly luciferase assay, and was used to monitor dipyridamole-induced blockade of ATP efflux by red cells. Results: In control experiments, red cells became more rigid after perfusion (slope values: 0.62 ± 0.09 vs. 0.40 ± 0.04; P < 0.05). Absence of platelets or treatment of red cells with aspirin and/or dipyridamole prevented the increased stiffness of red cells observed after exposure of blood to flow conditions. Moreover, a significant increase in red cell deformability was observed when blood was treated with dipyridamole alone or combined with aspirin (0.69 ± 0.07 and 0.65 ± 0.05 respectively vs. 0.40 ± 0.04; P < 0.05). Treatment with dipyridamole alone or combined with aspirin caused a decrease in ATP levels. Statistical significance was reached when red cells alone were treated with dipyridamole alone (45.8 ± 2.8 vs. 173.3 ± 47.6 ng ATP/ml; P < 0.05). Conclusions: Flow stress induced a decrease in red cell deformability probably linked to platelet activation. Treatment with dipyridamole alone or associated with aspirin eliminated the effect of flow, increasing red cell deformability. Under our experimental conditions, modifications could not be ascribed to red cell-released ATP. Our results emphasize the importance of blood flow conditions to evaluate RBC deformability.

KEYWORDS Blood flow; Human, red blood cells; Rheology; Platelets; Dipyridamole; Aspirin


* Tel. (+34-3)454.60.00; Fax (+34-3)454.26.14.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.